Improved Revenues Required Before Zhejiang Starry Pharmaceutical Co.,Ltd. (SHSE:603520) Stock's 28% Jump Looks Justified

Zhejiang Starry Pharmaceutical Co.,Ltd. (SHSE:603520) shareholders are no doubt pleased to see that the share price has bounced 28% in the last month, although it is still struggling to make up recent

Simply Wall StApr 6 20:39 ET

These 4 Measures Indicate That Zhejiang Starry PharmaceuticalLtd (SHSE:603520) Is Using Debt In A Risky Way

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' It's only natural to consider a company's balance sheet wh

Simply Wall StMar 27 22:25 ET

Stary (603520.SH)'s application for fixed addition was approved by the China Securities Regulatory Commission

Stelli (603520.SH) announced that the company received it from the China Securities Regulatory Commission on March 13, 2024...

Zhitong FinanceMar 13 07:02 ET

Zhejiang Starry PharmaceuticalLtd (SHSE:603520) Adds CN¥435m to Market Cap in the Past 7 Days, Though Investors From Three Years Ago Are Still Down 77%

It's nice to see the Zhejiang Starry Pharmaceutical Co.,Ltd. (SHSE:603520) share price up 13% in a week. But only the myopic could ignore the astounding decline over three years. In that time the

Simply Wall StFeb 27 01:04 ET

Zhejiang Starry Pharmaceutical Co.,Ltd. (SHSE:603520) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough

To the annoyance of some shareholders, Zhejiang Starry Pharmaceutical Co.,Ltd. (SHSE:603520) shares are down a considerable 26% in the last month, which continues a horrid run for the company. For

Simply Wall StJan 31 18:26 ET

Stari (603520.SH): Net profit pre-profit of 40 million yuan to 50 million yuan in 2023

Gelonghui, January 30丨Stelli (603520.SH) announced the 2023 annual results forecast. According to preliminary estimates by the finance department, it is expected to achieve net profit of 40 million yuan to 50 million yuan for the full year of 2023. Compared with the same period last year, it will turn a loss into a profit. It is expected to achieve net profit of 30 million yuan to 40 million yuan after deducting non-recurring profit and loss attributable to the owners of the parent company in 2023.

Gelonghui FinanceJan 30 08:31 ET